PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Daiichi Sankyo Company, Limited

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (5)

Compared with Healthcare companies in Japan.

P/E ratio

19.9

Investors pay 19.9 for every 1 of Daiichi Sankyo Company, Limited's yearly profit, higher than 73% of Healthcare companies in Japan.

P/B ratio

2.81

The share price is 2.81 times Daiichi Sankyo Company, Limited's book value per share, higher than 83% of Healthcare companies in Japan.

Market cap

¥4,792.1 B

The total market value of all of Daiichi Sankyo Company, Limited's shares at today's price (share price × number of shares), larger than 95% of Healthcare companies in Japan. PosiCap size class: Tito Cap.

Return on equity (ROE)

14.8%

Daiichi Sankyo Company, Limited earned 14.8% on its shareholders' money over the last year, higher than 78% of Healthcare companies in Japan.

Dividend yield

3.55%

Daiichi Sankyo Company, Limited pays 3.55% of its share price as dividends a year, higher than 81% of dividend-paying Healthcare companies in Japan.

Questions

What is Daiichi Sankyo Company, Limited's P/E ratio?

Investors pay 19.9 for every 1 of Daiichi Sankyo Company, Limited's yearly profit, higher than 73% of Healthcare companies in Japan.

What is Daiichi Sankyo Company, Limited's return on equity?

Daiichi Sankyo Company, Limited earned 14.8% on its shareholders' money over the last year, higher than 78% of Healthcare companies in Japan.

Does Daiichi Sankyo Company, Limited pay a dividend?

Yes. Daiichi Sankyo Company, Limited pays 3.55% of its share price as dividends a year, higher than 81% of dividend-paying Healthcare companies in Japan.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.